{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:20:12Z","timestamp":1789885212601,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T00:00:00Z","timestamp":1491264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.03.090","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T12:17:14Z","timestamp":1491653834000},"page":"2647-2653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Intranasal and sublingual delivery of inactivated polio vaccine"],"prefix":"10.1016","volume":"35","author":[{"given":"Heleen","family":"Kraan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Soema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Amorij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.090_b0005","unstructured":"Global Polio Eradication Initiative. History of polio. Available from: <http:\/\/polioeradication.org\/> [accessed on 3 January 2017]."},{"key":"10.1016\/j.vaccine.2017.03.090_b0010","unstructured":"Global Polio Eradication Initiative. Polio eradication & endgame strategic plan 2013\u20132018; 2013. Available from: <http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf> [accessed on 3 January 2017]."},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.03.090_b0015","doi-asserted-by":"publisher","first-page":"S459","DOI":"10.1093\/infdis\/jiu128","article-title":"Affordable inactivated poliovirus vaccine: strategies and progress","volume":"210","author":"Okayasu","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.090_b0020","doi-asserted-by":"publisher","first-page":"e83374","DOI":"10.1371\/journal.pone.0083374","article-title":"Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals","volume":"8","author":"Thomassen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.090_b0025","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1016\/j.vaccine.2013.09.021","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults","volume":"31","author":"Verdijk","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0030","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1016\/j.vaccine.2014.07.029","article-title":"Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants","volume":"32","author":"Verdijk","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0035","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1016\/j.vaccine.2014.07.109","article-title":"Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I Trial in healthy adults in Cuba","volume":"32","author":"Resik","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0040","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1586\/14760584.2016.1158650","article-title":"Alternative administration routes and delivery technologies for polio vaccines","volume":"15","author":"Kraan","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.090_b0045","doi-asserted-by":"publisher","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.03.090_b0050","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.vaccine.2014.02.022","article-title":"Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods","volume":"32","author":"Thomassen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0055","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1016\/j.vaccine.2013.05.104","article-title":"Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults","volume":"31","author":"Soonawala","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0060","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.vaccine.2012.12.076","article-title":"Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains","volume":"31","author":"Westdijk","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0065","article-title":"Alternative administration routes and delivery technologies for polio vaccines","volume":"1\u201312","author":"Kraan","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.090_b0070","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.vaccine.2007.10.045","article-title":"Towards an oral influenza vaccine: comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model","volume":"26","author":"Amorij","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0075","doi-asserted-by":"publisher","first-page":"7851","DOI":"10.4049\/jimmunol.0803740","article-title":"Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection","volume":"183","author":"Cuburu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.090_b0080","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/imm.12676","article-title":"Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization","volume":"150","author":"Sjokvist Ottsjo","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2017.03.090_b0085","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1128\/IAI.63.3.853-857.1995","article-title":"Induction of compartmentalized B-cell responses in human tonsils","volume":"63","author":"Quiding-Jarbrink","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.090_b0090","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1172\/JCI119286","article-title":"Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses","volume":"99","author":"Quiding-Jarbrink","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2017.03.090_b0095","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1084\/jem.20090858","article-title":"Dynamic T cell migration program provides resident memory within intestinal epithelium","volume":"207","author":"Masopust","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.03.090_b0100","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature10228","article-title":"Control of TH17 cells occurs in the small intestine","volume":"475","author":"Esplugues","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.03.090_b0105","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/infdis\/jiw162","article-title":"Intranasal vaccination with salmonella-derived serodominant secreted effector protein B associated with gas-filled microbubbles partially protects against gut infection in mice","volume":"214","author":"Pigny","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.090_b0110","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1084\/jem.20122762","article-title":"Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract","volume":"210","author":"Ruane","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.03.090_b0115","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.coi.2012.03.014","article-title":"Vaccines against mucosal infections","volume":"24","author":"Holmgren","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2017.03.090_b0120","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1002\/eji.1830261108","article-title":"Identification of an immunodominant T cell epitope on cholera toxin","volume":"26","author":"Cong","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.090_b0125","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1473-3099(10)70157-2","article-title":"Needle-free influenza vaccination","volume":"10","author":"Amorij","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.090_b0130","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2017.03.090_b0135","doi-asserted-by":"publisher","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.090_b0140","doi-asserted-by":"publisher","first-page":"8598","DOI":"10.1016\/j.vaccine.2007.09.073","article-title":"Sublingual immunization induces broad-based systemic and mucosal immune responses in mice","volume":"25","author":"Cuburu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0145","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1073\/pnas.0708684105","article-title":"Sublingual vaccination with influenza virus protects mice against lethal viral infection","volume":"105","author":"Song","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.03.090_b0150","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/1743-422X-9-215","article-title":"Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain","volume":"9","author":"Shim","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2017.03.090_b0155","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.4161\/hv.32253","article-title":"Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system","volume":"10","author":"White","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.03.090_b0160","doi-asserted-by":"publisher","first-page":"6558","DOI":"10.1016\/j.vaccine.2009.08.047","article-title":"CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus","volume":"27","author":"Yang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0165","first-page":"1846","article-title":"Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats","volume":"31","author":"van der Maaden","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2017.03.090_b0170","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1007\/s11095-014-1359-6","article-title":"Development of thermostable lyophilized inactivated polio vaccine","volume":"31","author":"Kraan","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2017.03.090_b0175","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.vaccine.2015.03.011","article-title":"Alternative delivery of a thermostable inactivated polio vaccine","volume":"33","author":"Kraan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.090_b0180","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1016\/j.vaccine.2016.07.030","article-title":"Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine","volume":"34","author":"Kraan","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T05:46:50Z","timestamp":1601876810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17304425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":36,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X17304425"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal and sublingual delivery of inactivated polio vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}